tm logo
LUNDBECK INSTITUTE
Live/Pending
NON-FINAL ACTION - MAILED

final action

on 04 Dec 2024

Last Applicant/ Owned by

Ottiliavej 9

Valby

DK

DK-2500

Serial Number

98553547 filed on 16th May 2024

Registration Number

N/A

Correspondent Address

Maren C. Perry

Maren C. Perry King & Spalding LLP

New York, NY 10036

United States

Filing Basis

No Filing Basis

Disclaimer

NO DATA

LUNDBECK INSTITUTE

Pharmaceutical research and development; scientific and technological services, namely, scientific testing and research related to medical disorders, medical diseases and medical prevention; scientific and technological services, namely, scientific testing and research related to the central nervous system and central nervous system related disorders, pharmaceuticals and disease awareness; medical Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical research and development; scientific and technological services, namely, scientific testing and research related to medical disorders, medical diseases and medical prevention; scientific and technological services, namely, scientific testing and research related to the central nervous system and central nervous system related disorders, pharmaceuticals and disease awareness; medical and clinical research, namely, pharmaceutical clinical research and conducting clinical trials for others in the field of pharmaceuticals; diagnostic research and tests in the field of pharmaceutical research


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [041]
Education and Entertainment Services


Educational services, namely, conducting seminars in the field of pharmaceuticals and disease awareness; providing of training in the field of pharmaceuticals and disease awareness; arranging and conducting seminars, conferences, symposiums, training workshops and courses in the field of pharmaceuticals and disease awareness; educational training services in the fields of pharmaceutical research and development, medical clinical studies, pharmaceutical tests and trials and diagnostic medicine related to the treatment and prevention of diseases and disorders; providing the aforementioned services electronically, on-line, via cable or Internet or other electronic media; arranging and conducting expert forums, namely, on-line training programs in the field of pharmaceuticals; providing on-line, non-downloadable publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of pharmaceutical research and development, science, medical clinical studies in the field of pharmaceutical tests and trials, diagnostic medicine, pharmaceuticals, disorders, disease awareness, treatment and prevention related to the assessment of cognitive functions; providing educational assessment services in the field of cognitive functions through on-line non-downloadable screening tools


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [016]
Paper Goods and Printed Material


Printed publications, including books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, records, educational and training materials for research and development, science, clinical studies, tests and trials, diagnostics, medicine, drugs, disorders, diseases, treatment and prevention


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [009]
Computer & Software Products & Electrical & Scientific Products


Downloadable electronic publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of pharmaceutical research and development, disease awareness, medical clinical studies, pharmaceutical tests and trials, diagnostic medicine, medicine, pharmaceuticals, disorders, diseases, clinical or medical treatment and prevention; software for medical and pharmaceutical information, education and sales activities; software for analyzing medical and pharmaceutical information and disease awareness; software, namely, application software for mobile devices for analyzing medical and pharmaceutical information;  apparatus and instruments for analyzing medical and pharmaceutical information in the field of research and development, science, clinical studies, medical clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; electronic downloadable publications, namely, magazines, journals, teaching and educational materials in the field of pharmaceutical research and development, science, medical clinical studies, pharmaceutical tests and trials, diagnostic medicine related to clinical or medical treatment and prevention; application software for mobile devices for the assessment of cognitive functions; downloadable software for assessment of cognitive functions; software for use in diagnosing, managing, monitoring, assessing, controlling and examining psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy,  Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, migraine, pain, alcoholism and dependency


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [038]
Communications Services


Arranging and conducting an online forum in the field of pharmaceuticals, disease awareness and treatments; providing online chat rooms and electronic bulletin boards for transmission of messages among users in the field of pharmaceuticals, disease awareness and treatments


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical and medicinal preparations and substances; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances, acting on the central nervous system; central nerve system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, attack, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood swings, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinsons disease and disorder, falls, movement disorders and movement disorders, tremor, schizophrenia, bipolar disorder and suffering, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourettes syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, drowsiness, nausea, migraine, pain, alcoholism and addiction; compositions, drugs, reagents and agents for diagnostic and medical purposes


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98553547

Mark Type

No Service Mark

Attorney Docket Number

No 26657.104004

44D Filed

Yes

44D Current

Yes

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
04th Dec 2024NON-FINAL ACTION WRITTEN
04th Dec 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
04th Dec 2024NON-FINAL ACTION E-MAILED
02th Dec 2024ASSIGNED TO EXAMINER
18th Nov 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16th May 2024NEW APPLICATION ENTERED